Benzothiophene carboxamide derivatives as inhibitors of Plasmodium falciparum enoyl-ACP reductase

IUBMB Life

Volumn 63, Issue 12, 2011, Pages 1101-1110

  Banerjee, Tanushree ^a   Sharma, Shailendra Kumar ^b   Kapoor, Neha ^a   Dwivedi, Vishnu ^a   Surolia, Namita ^c   Surolia, Avadhesha ^a  

^a NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^b INDIAN INSTITUTE OF SCIENCE   (India)

^c JAWAHARLAL NEHRU CENTRE FOR ADVANCED SCIENTIFIC RESEARCH   (India)

Author keywords

Antimalarials; Benzothiophene carboxamide; Bromo benzothiophene; Plasmodium

Indexed keywords

3 BROMO N (4 FLUOROBENZYL)BENZO[B]THIOPHENE 2 CARBOXAMIDE; 3 BROMO N [4 (TRIFLUOROMETHYL)BENZYL]BENZO[B]THIOPHENE 2 CARBOXAMIDE; AMIDE; ANTIMALARIAL AGENT; BENZOTHIOPHENE DERIVATIVE; COENZYME A; CROTONOYL COENZYME A; ENOYL ACYL CARRIER PROTEIN REDUCTASE; ENOYL ACYL CARRIER PROTEIN REDUCTASE INHIBITOR; OXIDOREDUCTASE; OXIDOREDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG SYNTHESIS; IC 50; NONHUMAN; PLASMODIUM FALCIPARUM; STRUCTURE ACTIVITY RELATION;

ANTIMALARIALS; ENOYL-(ACYL-CARRIER-PROTEIN) REDUCTASE (NADH); ENZYME INHIBITORS; HUMANS; INHIBITORY CONCENTRATION 50; MALARIA, FALCIPARUM; MOLECULAR STRUCTURE; PLASMODIUM FALCIPARUM; THIOPHENES;

EID: 84055193727     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.553     Document Type: Article

References (41)

1. Peters, W. (1998) Drug resistance in malaria parasites of animals and human. Adv. Parasitol. 41, 1-62.
2. Krogstad, D. J., Gluzman, I. V., Kyle, D. E., Oduola, A. M. J., Martins, S. K., Milhouse, W. K., and Schlesinger, P. H. (1987) Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238, 1283-1285.
3. Bray, P. G., Mungthin, M., Riley, R. G., and Ward, S. A. (1998) Access to hematin the basis of chloroquine resistance. Mol. Pharmacol. 54, 170-179. (Pubitemid 28337600)
4. Mutabingwa, T. K., Anthony, D., Heller, A., Hallett, R., Ahmed, J., et al. (2005) Amodiaquine alone, amodiaquine 1 sulfadoxine-pyrimethamine, amodiaquine 1 artesunate, and artemether-lumefantrine for outpatient treatment of malaria in Tanzanian children: a four-arm randomised effectiveness trial. Lancet 365, 1474-1480. (Pubitemid 40591692)
5. Rathod, P. K., McErlean, T., and Lee, P. C. (1997) Variations in the frequencies of drug resistance in Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 94, 9389-9393. (Pubitemid 27357839)
6. WHO. 1999. Rolling back malaria. In: The World Health Report 1999: making a difference. Geneva. Switzerland. pp. 49-63.
7. Smith, S., Witkowski, A., and Joshi, A. K. (2003) Structural and functional organization of the animal fatty acid synthase. Prog. Lipid Res. 42, 289-317. (Pubitemid 36411688)
8. Ralph, S. A., Van Dooren, G. G., Waller, R. F., Crawford, A. F., Fraunholz, M., et al. (2004) Metabolic maps and functions of the Plasmodium falciparum apicoplast. Nat. Rev. Microbiol. 2, 203-216. (Pubitemid 39490083)
9. Rock, C. O. and Cronan, J. E. (1996) Escherichia coli as a model for the regulation of dissociable (type II) fatty acid biosynthesis. Biochim. Biophys. Acta 132, 1-16. (Pubitemid 26267038)
10. Surolia, N. and Surolia, A. (2001) Triclosan offers protection against blood-stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum. Nat. Med. 7, 167-173. (Pubitemid 32148482)
11. Heath, R. J. and Rock, C. O. (2004) Fatty acid biosynthesis as a target for novel antibacterials. Curr. Opin. Investig. Drugs 5, 46-53.
12. Singh, A. P., Surolia, N., and Surolia, A. (2009) Triclosan inhibit the growth of the late liver-stage of Plasmodium. IUBMB Life. 61, 923-928.
13. Vaughan, A. M., O'Neill, M. T., Tarun, A. S., Camargo, N., Phuong, T. M., et al. (2009) Type II fatty acid is essential for only late liver-stage development. Cell. Microbiol. 11, 506-520.
14. Mahmoudi, N., Ciceron, L., Franetich, J. F., Farhati, K., Silvie, O., et al. (2003) In vitro activities of 25 quinolones and fluoroquinolones against liver and blood-stage Plasmodium spp. Antimicrob. Agents Chemother. 47, 2636-2639. (Pubitemid 36919470)
15. Surolia, A., Ramya, T. N. C., Ramya, V., and Surolia, N. (2004) 'FAS't inhibition of malaria. Biochem. J. 383, 410-412.
16. Chhibber, M., Kumar, G., Parasuraman, P., Ramya, T. N., and Surolia, N., Surolia, A. (2006) Novel diphenyl ethers: design, docking studies, synthesis, and inhibition of enoyl ACP reductase of Plasmodium falciparum and Escherichia coli. Bioorg. Med. Chem. 14, 886-898.
17. Kumar, S., Kumar, G., Kapoor, M., Surolia, A., and Surolia, N. (2006) Synthesis and evaluation of substituted pyrazoles: potential anti-malarials targeting the enoyl ACP reductase of Plasmodium falciparum. Synth. Commun. 36, 215-226. (Pubitemid 43127925)
18. Sharma, S. K., Prasanna, P., Kumar, G., Surolia, N., and Surolia, A. (2007) Green tea catechins potentiate triclosan binding to enoyl-ACP reductase from Plasmodium falciparum (PfENR). J. Med. Chem. 50, 765-775. (Pubitemid 46332989)
19. Malamas, M. S., Sredy, J., Moxham, C., Katz, A., Xu, W., et al. (2000) Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B and antihyperglycemic properties. J. Med. Chem. 43, 1293-1310. (Pubitemid 30212571)
20. Qin, Z., Kastrati, I., Ashqodom, R. T., Lantvit, D. D., Overk, C. R., et al. (2009) Structural modulation of oxidative metabolism in design of improved benzothiophene selective estrogen receptor modulators. Drug Metab. Dispos. 37, 161-169.
21. Bolognese, M., Krege, J. H., Utian, W. H., Feldman, R., Broy, S., et al. (2009) Effects of arzoxifene on bone mineral density and endometrium in post menopausal women with normal or low bone mass. J. Clin. Endocrinol. Metab. 94, 2284-2289.
22. Thorneloe, K. S., Sulpizio, A. C., Lin, Z., Fiqueroa, D. J., Clouse, A. K., et al. (2008) N-((1S)-1-{[4-((2S)-2-[(2,4-Dichlorophenyl) sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl) -1-benzothiophene-2-carboxamide (GSK116790A), a novel and potent transient receptor potential vanilloid 4 channel agonist induces urinary bladder contraction and hyperactivity. Part I. J. Pharmacol. Exp. Ther. 326, 432-442.
23. Villar, R., Encio, I., Miqliaccio, M., Gil, M. J., and Martinez-Merino, V. (2004) Synthesis and cytotoxic activity of lipophillic sulphonamide derivatives of the benzo[b]thiophene 1, 1 dioxide. Bioorg. Med. Chem. 12, 963-968. (Pubitemid 38251289)
24. Youngs, C. G., Epp, A., Craig, B. M., and Sallans, H. R. (1956) Preparation of long-chain fatty acid chlorides. J. Am. Oil Chem. Soc. 34, 107-108.
25. Kim, K. S. and Kim, H. S. (2004) Molecular Tweezer based on chenodeoxycholic acid: synthesis and anion binding properties. Bull. Korean Chem. Soc. 25, 1411-1413.
26. Pidugu, L. S., Kapoor, M., Surolia, N., Surolia, A., and Suguna, K. (2004) Structural basis for the variation in triclosan affinity to enoyl reductases. J. Mol. Biol. 343, 147-155. (Pubitemid 39277454)
27. Molecular Operating Environment [MOE 201.7], Chemical Computing Group Inc., Montreal, Quebec, Canada, H3B 3X3.
28. Sobolev, V., Sorokine, A., Prilusky, J., Abola, E. E., and Edelmanm, M. (1999) Automated analysis of interatomic contacts in proteins. Bioinformatics 15, 327-332. (Pubitemid 29213759)
29. Kapoor, M., Mukhi, P. L., Surolia, N., Suguna, K., and Surolia, A. (2004) Kinetic and structural analysis of the increased affinity of enoyl-ACP (acylcarrier protein) reductase for triclosan in the presence of NAD1. Biochem. J. 381, 725-733. (Pubitemid 39120482)
30. Lack, G., Homberger-Zizzari, G., Folkers, G., Scapozza, L., and Perozzo, R. (2006) Recombinant expression and biochemical characterisation of the unique elongating beta-ketoacyl-acyl carrier protein synthase involved in fatty acid biosynthesis of Plasmodium falciparum using natural and artificial substrates. J. Biol. Chem. 281, 9538-9546. (Pubitemid 43864671)
31. Karmodiya, K. and Surolia, N. (2006) Analyses of co-operative transitions in Plasmodium falciparum beta-ketoacyl carrier protein reductase upon co-factor and acyl carrier protein binding. FEBS J. 273, 4093-4103. (Pubitemid 44253661)
32. Sharma, S. K., Kapoor, M., Kumar, S., Kumar, G., Modak, R., Sharma, S., Surolia, N., and Surolia, A. (2003) Identification, characterisation and inhibition of Plasmodium falciparum β-hydroxyacyl-acyl carrier protein dehydratase (FabZ). J. Biol. Chem. 278, 45661-45671. (Pubitemid 37432708)
33. Suguna, K., Surolia, A., and Surolia, N. (2001) Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum. Biochem. Biophys. Res. Commun. 283, 224-228. (Pubitemid 32912561)
34. Petrash, J. M., Harter, T. M., Devine, C. S., Olins, P. O., Bhatnagar, A., Liu, S., and Srivastava, S. K. (1992) Involvement of cysteine residues in catalysis and inhibition of human aldose reductase: Sitedirected mutagenesis of Cys-80,-298, and-303. J. Biol. Chem. 267, 24833-24840.
35. Suryanarayana, P., Kumar, P. A., Saraswat, M., Petrash, J. M., and Reddy, G. B. (2004) Inhibition of aldose reductase by tannoid principles of Emblica officinalis: implications for the prevention of sugar cataract. Mol. Vis. 10, 148-154. (Pubitemid 38658950)
36. Arslanian, M. J., Pascoe, E, and Reinhold, J. G. (1971) Rat liver alcohol dehydrogenase. Purification and properties. Biochem. J. 125, 1039-1047.
37. Kapoor, M., Dar, M. J., Surolia, A., and Surolia, N. (2001) Kinetic determination of the interaction of enoyl-ACP reductase from Plasmodium falciparum with its substrates and inhibitors. Biochem. Biophys. Res. Commun. 289, 832-837. (Pubitemid 34060079)
38. Kapoor, M., Reddy, C. C., Krishnasastry, M. V., Surolia, N., and Surolia, A. (2004) Slow-tight-binding inhibition of enoyl-acyl carrier protein reductase from Plasmodium falciparum by triclosan. Biochem. J. 381, 719-724. (Pubitemid 39120481)
39. Dixon, M. (1972) The graphical determination of Km and Ki. Biochem. J. 129, 197-202.
40. Morrison, J. F. and Walsh, C. (1988) The behaviour and significance of slow tight binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61, 21-31.
41. Morrison, J. F. (1982) The slow binding and slow tight binding inhibition of enzyme catalysed reactions. Trends Biochem. Sci. 7, 12-15.